HAVN Life Sciences, Inc. is a biotechnology company, which provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions. The firm engages in extraction of psychoactive compounds from plants and fungi and the development of natural health care products, and also mental health treatments to support mental health. The company was founded on April 8, 2020 and is headquartered in Port Moody, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for HAVN Life Sciences Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. HAVN Life Sciences Inc. 52 week high is $0.002 as of April 26, 2026.